Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
With panellists and attendees arriving from throughout Latin America, it also provided a chance to share learnings and best practices with far-flung regional partners. The conference provided an important and open forum for discussing of a wide range of topics including geopolitics, sustainable fuels, artificial intelligence, port upgrades, driver shortages and more.
Chile Mining 2025 Pre-Release
A resilient industry rising to meet its challenges
A convergence of high-commodity prices and low valuations, on the back of a structural deficit in exploration and discoveries, has set the perfect scene for increased M&A. The leverage is particularly high for acquisitions in Latam North and the Caribbean, where stocks do not command the high premiums of tier-one jurisdictions. But M&A is only a quick fix to the global resource replenishment crisis.
Mexico Chemicals 2025
Is there light at the end of the feedstock shortage tunnel?